EMA moving to Amsterdam – congratulations
The race for the new EU medicines authority is over and a decision has been made: Amsterdam will be the new site of the European Medicines Agency (EMA). The Paul-Ehrlich-Institut (PEI) sends its best wishes to the Netherlands and its congratulations for this special success.
"We are very happy to continue to provide our expertise in the field of vaccines and biomedicines since this enables us to support the EMA actively" says Professor Klaus Cichutek, president of the PEI.
It is vital for Europe that the EMA is able to run its daily business for an efficient collaboration of the regulatory authorities. A speedy relocation is an important prerequisite. It guarantees that the EMA is constantly and rapidly available to the experts of the European regulatory authorities.